Correlation between late gadolinium enhancement and diastolic function in hypertrophic cardiomyopathy assessed by

Munenobu Motoyasu1, Tairo Kurita, Katsuya Onishi

  • 1Department of Cardiology, Mie University Graduate School of Medicine, Tsu, Japan.

Insights

The extent of myocardial fibrosis in hypertrophic cardiomyopathy (HCM) patients, measured by late gadolinium-enhanced MRI, strongly correlates with diastolic dysfunction. This finding highlights the link between fibrosis and impaired heart function in HCM.

Area of Science:

  • Cardiovascular Imaging
  • Cardiac MRI
  • Cardiomyopathy Research

Background:

  • Diastolic dysfunction is a prevalent issue in patients diagnosed with overt hypertrophic cardiomyopathy (HCM).
  • Steady-state cine magnetic resonance imaging (MRI) is a key tool for assessing left ventricular (LV) diastolic function.
  • Late gadolinium-enhanced MRI (LGE-MRI) effectively visualizes myocardial fibrosis in HCM patients.

Purpose of the Study:

  • To investigate the relationship between the extent of myocardial fibrosis, as detected by LGE-MRI, and the presence of diastolic dysfunction in HCM patients.

Main Methods:

  • Seventeen HCM patients underwent LGE-MRI to quantify myocardial fibrosis severity and cine MRI to assess LV diastolic function parameters, including peak filling rate (PFR) and LV ejection fraction.
  • Fibrosis extent was evaluated using a severity index based on scoring enhanced tissue across 30 myocardial segments.
  • Correlation analyses were performed between the LGE severity index and diastolic function metrics.

Main Results:

  • LGE-MRI revealed myocardial fibrosis in 77% of patients (13 out of 17), affecting 19% of myocardial segments analyzed.
  • A significant negative correlation was found between the LGE severity index and both PFR (r = -0.86, p<0.01) and LV ejection fraction (r = -0.59, p<0.05).
  • No significant correlation was observed between fibrosis extent and LV mass (r = 0.23, p=0.30).

Conclusions:

  • The degree of myocardial fibrosis, as quantified by LGE-MRI, is strongly associated with diastolic dysfunction in patients with hypertrophic cardiomyopathy.
  • LGE-MRI is a valuable tool for understanding the pathophysiological mechanisms underlying diastolic dysfunction in HCM.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...